Renovaro Biosciences Inc.

NASDAQ: RENB · Real-Time Price · USD
0.36
0.05 (16.54%)
At close: Jun 09, 2025, 3:59 PM
16.54%
Bid 0.3
Market Cap 61.79M
Revenue (ttm) 181.45K
Net Income (ttm) -67.01M
EPS (ttm) -0.25
PE Ratio (ttm) -1.44
Forward PE n/a
Analyst n/a
Ask 0.4
Volume 3,120,605
Avg. Volume (20D) 2,364,422
Open 0.32
Previous Close 0.31
Day's Range 0.31 - 0.37
52-Week Range 0.27 - 2.34
Beta 0.53

About RENB

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RENB
Website n/a
Full Company Profile
4 weeks ago
-0.66%
RENB stock has given up its prior gain. Renovaro s... Unlock content with Pro Subscription
4 weeks ago
-0.66%
Renovaro shares are trading higher after the company announced its subsidiary, BioSymetrics, received a Notice of Allowance from the United States Patent and Trademark Office for a new patent application titled "Methods, Systems, and Frameworks for Unbiased Data in Drug Discovery Predictions"